Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Innovation Pharmaceuticals Inc (OP:IPIX)

0.0007 -0.0002 (-22.22%)

Streaming Delayed Price Updated: 12:51 PM EST, Feb 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,609
Open	0.0007
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0009
Today's Range	0.0007 - 0.0007
52wk Range	0.0001 - 0.0186
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

August 28, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases

June 21, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	-30.0%	-30.0%
1 Month	-30.0%	-30.0%
3 Month	N/A	N/A
6 Month	+40.0%	+40.0%
1 Year	+600.0%	+600.0%

More News

Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing

June 05, 2023

Via NewMediaWire

Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

April 17, 2023

Via NewMediaWire

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

March 15, 2023

Via NewMediaWire

Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission

February 23, 2023

Via NewMediaWire

Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement

January 09, 2023

Via NewMediaWire

Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin's Potential for Treating Fungal Keratitis

December 13, 2022

Via NewMediaWire

Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family

November 28, 2022

Via NewMediaWire

Scientific Poster on Innovation Pharmaceuticals Brilacidin to be Presented at 2022 Chemical and Biological Defense Science & Technology Conference

November 15, 2022

Via NewMediaWire

NHS Medical Director for Specialised Services Calls New Laser Technology for Epilepsy "Game-Changing Breakthrough"

October 26, 2022

Via NewMediaWire

New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals' Brilacidin Presented at 2022 Military Health System Research Symposium

September 15, 2022

Via ACCESSWIRE

Innovation Pharmaceuticals' Investment in BT BeaMedical Helping Advance New Surgical Laser Platform

September 13, 2022

Via ACCESSWIRE

Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin's Treatment Potential Against Monkeypox

August 05, 2022

Via ACCESSWIRE

Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate

July 22, 2022

Via ACCESSWIRE

Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate

July 22, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium

June 28, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers

June 23, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology

June 15, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Announces Publication of Peer-Review Article in the Journal of Medical Virology on Anti-Coronavirus Properties of Brilacidin

March 15, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Reports Additional Findings Based on Review of Brilacidin Phase 2 COVID-19 Trial Results and Compassionate Use Cases

March 07, 2022

From Innovation Pharmaceuticals Inc.

Via AccessWire

These OTC Securities Had the Most Trading Activity in November ↗

December 16, 2021

Via Benzinga

Innovation Pharmaceuticals Analyzing Full Dataset for Its Brilacidin COVID-19 Clinical Trial; Company Evaluating New Pipeline Opportunities for 2022

December 07, 2021

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Provides Brilacidin Program Update

November 18, 2021

From Innovation Pharmaceuticals Inc.

Via AccessWire

Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin's Potential Inclusion in Government-Sponsored COVID-19 Trials

November 12, 2021

From Innovation Pharmaceuticals Inc.

Via AccessWire

Frequently Asked Questions

Is Innovation Pharmaceuticals Inc publicly traded?

Yes, Innovation Pharmaceuticals Inc is publicly traded.

What exchange does Innovation Pharmaceuticals Inc trade on?

Innovation Pharmaceuticals Inc trades on the OTC Traded

What is the ticker symbol for Innovation Pharmaceuticals Inc?

The ticker symbol for Innovation Pharmaceuticals Inc is IPIX on the OTC Traded

What is the current price of Innovation Pharmaceuticals Inc?

The current price of Innovation Pharmaceuticals Inc is 0.0007

When was Innovation Pharmaceuticals Inc last traded?

The last trade of Innovation Pharmaceuticals Inc was at 02/02/26 12:51 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.